CORC  > 高能物理研究所
A carrier-free nanostructure based on platinum(iv) prodrug enhances cellular uptake and cytotoxicity
Tan, Jingjie1,2; Li, Chan2,3; Wang, Qian2; Li, Shuyi2; Chen, Shizhu2,4; Zhang, Jinchao4; Wang, Paul C.5; Ren, Lei1; Liang, Xing-Jie2
刊名Molecular pharmaceutics
2018-04-01
卷号15期号:4页码:1724-1728
关键词Cisplatin Nanostructure Carrier-free Cyclooxygenase inhibitor Cellular uptake
ISSN号1543-8384
DOI10.1021/acs.molpharmaceut.8b00070
通讯作者Li, chan(lichanster@163.com) ; Ren, lei(renlei@xmu.edu.cn) ; Liang, xing-jie(liangxj@nanoctr.cn)
英文摘要Flurbiprofen, a hydrophobic cox inhibitor, was coordinated axially with oxoplatin to form a new conjugate, cis,cis,trans-[pt(iv)(nh3)(2)cl-2(flurbiprofen)(2)]. the successful synthesis of this new conjugate was confirmed by h-1, c-13, and pt-195 nmr. the potential of this conjugate being reduced to cisplatin and subsequently exerting its dna cross-linking ability was verified using cyclic voltammetry (cv), hplc, and mass spectrometry (ms). this conjugate showed markedly higher cytotoxicity on many cancer cell lines than cisplatin, flurbiprofen, and their physical mixture (mole ratio, cisplatin:flurbiprofen = 1:2). this is consistent with the result of an apoptosisinducing assay. this conjugate spontaneously assembles carrier-free nanopartides in aqueous solution, which is confirmed by dls, tem, sem, and afm, and thus facilitates cellular uptake and markedly improves its cytotoxicity and apoptosis-inducing ability in vitro.
WOS关键词EMISSION AIE CHARACTERISTICS ; CISPLATIN RESISTANCE ; CANCER-CELLS ; TUMOR-CELLS ; IN-SITU ; CYCLOOXYGENASE INHIBITORS ; DRUG ACTIVATION ; ASPIRIN ; NANOPARTICLES ; DELIVERY
WOS研究方向Research & Experimental Medicine ; Pharmacology & Pharmacy
WOS类目Medicine, Research & Experimental ; Pharmacology & Pharmacy
语种英语
出版者AMER CHEMICAL SOC
WOS记录号WOS:000429283300035
内容类型期刊论文
URI标识http://www.corc.org.cn/handle/1471x/2178136
专题高能物理研究所
通讯作者Li, Chan; Ren, Lei; Liang, Xing-Jie
作者单位1.Xiamen Univ, Coll Mat, Key Lab Biomed Engn Fujian Prov, Dept Biomat, Xiamen 361005, Peoples R China
2.Chinese Acad Sci, Ctr Excellence Nanosci, CAS Key Lab Biomed Effects Nanomat & Nanosafety, Natl Ctr Nanosci & Technol, Beijing 100190, Peoples R China
3.Peking Univ, Sch Life Sci, Beijing 100871, Peoples R China
4.Hebei Univ, Coll Chem & Environm Sci, Baoding 071002, Peoples R China
5.Howard Univ, Dept Radiol, Washington, DC 20060 USA
推荐引用方式
GB/T 7714
Tan, Jingjie,Li, Chan,Wang, Qian,et al. A carrier-free nanostructure based on platinum(iv) prodrug enhances cellular uptake and cytotoxicity[J]. Molecular pharmaceutics,2018,15(4):1724-1728.
APA Tan, Jingjie.,Li, Chan.,Wang, Qian.,Li, Shuyi.,Chen, Shizhu.,...&Liang, Xing-Jie.(2018).A carrier-free nanostructure based on platinum(iv) prodrug enhances cellular uptake and cytotoxicity.Molecular pharmaceutics,15(4),1724-1728.
MLA Tan, Jingjie,et al."A carrier-free nanostructure based on platinum(iv) prodrug enhances cellular uptake and cytotoxicity".Molecular pharmaceutics 15.4(2018):1724-1728.
个性服务
查看访问统计
相关权益政策
暂无数据
收藏/分享
所有评论 (0)
暂无评论
 

除非特别说明,本系统中所有内容都受版权保护,并保留所有权利。


©版权所有 ©2017 CSpace - Powered by CSpace